PBLA

0.000150.00%
AJ

Arthur J. Fratamico

Independent Director

Mr. Arthur J. Fratamico, R.Ph. MBA, also known as Art, serves as Chief Executive Officer and President of Radiant Biotherapeutics Inc. He serves as Chief Executive Officer at RADIANT BIOTHERAPEUTICS INC. He served as Chief Business Officer of Galera Therapeutics, Inc. since January 2017. a biopharmaceutical company dedicated to discovering and developing novel dismutase mimetics with the goal of transforming cancer radiotherapy, since January 2017. He has been an Independent Director of Panbela Therapeutics Inc. (formerly known as Sun BioPharma, Inc.) since December 16, 2019. Mr. Fratamico served as the Chief Business Officer of Vitae Pharmaceuticals, Inc. from May 2014 to December 2016. Mr. Fratamico has experience in the pharmaceutical and biotechnology industries. He served as the Chief Business Officer of Flexion Therapeutics, Inc. since June 2012. Mr. Fratamico served as Chief Business Officer of Trevena, Inc. until April 17, 2012. He served as Senior Vice President of Corporate Development at Trevena, Inc. He served as Chief Business Officer of Gemin X Pharmaceuticals, Inc. from 2008 to 2011. Mr. Fratamico served as Vice President of Business & Strategic Development at Gemin X Pharmaceuticals, Inc. He is a registered pharmacist with experience in the pharmaceutical industry. He served as Vice President of Business Development & Licensing at MGI Pharma, Inc. He established the business development function and licensing process, evaluating corporate acquisitions, external corporate communications, recommending deal structures and terms with respect to in-licensing, out-licensing, co-promotion, alliance opportunities, as well as developing and implementing corporate strategic and tactical commercial plans for new products and therapeutic franchises. Prior to MGI, he served at Hoechst Marion Roussel in various assignments, including sales, product marketing and commercial development. Focused on oncology, anti-infectives and biologics, he led cross-functional teams in preparation for the launch and marketing of HMR products. He also served in several senior marketing, product planning and new product development positions. Mr. Fratamico is a Registered Pharmacist with a Bachelor of Science degree in Pharmacy from Philadelphia College of Pharmacy and Science and earned a Master of Business Administration degree with a dual concentration in Marketing and Finance from Drexel University.

Positions